Individual- and Regional-level determinants of Human Papillomavirus (HPV) vaccine refusal: The Ontario Grade 8 HPV vaccine cohort study

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Remes, Olivia ^a   Smith, Leah M ^b   Alvarado Llano, Beatriz E ^a   Colley, Lindsey ^a   Lévesque, Linda E ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cohort studies; HPV vaccine; Human papillomavirus; Vaccine coverage; Vaccine hesitancy

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; CANADA; CHILD; COHORT ANALYSIS; FEMALE; HUMAN; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATIENT ATTITUDE; POPULATION RESEARCH; POVERTY; RETROSPECTIVE STUDY; TREATMENT REFUSAL; UTILIZATION; VACCINATION; VIROLOGY;

ADOLESCENT; ADULT; CANADA; CENSUSES; CHILD; COHORT STUDIES; FEMALE; HUMANS; ONTARIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; POVERTY; RETROSPECTIVE STUDIES; TREATMENT REFUSAL; VACCINATION;

EID: 84937863033     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-1047     Document Type: Article

References (41)

1. Syrjanen K, Hakama M, Saarikoski S, Vayrynen M, Yliskoski M, Syrjanen S, Kataja V, Castren O: Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis 1990, 17(1):15-19.
2. Patel H, Wagner M, Singhal P, Kothari S: Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis 2013, 13:39.
3. Gall SA: Female genital warts: global trends and treatments. Infect Dis Obstet Gynecol 2001, 9:149-154.
4. Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, Fukumoto L: External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 2002, 35:S210-S224.
5. Munoz N, Bosch FX, Castellsaque X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ: Against which human papillomavirus types shall we vaccinate and screen? The International Perspective. Int J Cancer 2004, 111(2):278-285.
6. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121(3):621-632.
7. Brisson M, Van De Velde N, Boily MC, De Wals P: The health and economic burden of HPV infection, genital warts, cervical dysplasia and cervical cancer in Canada. Can J Infect Dis Med Microbiol 2006, 17(6):348-349.
8. Parry J: Vaccinating against cervical cancer. Bull World Health Organ 2007, 85(2):89-90.
9. Colucci R, Hryniuk W, Savage C: HPV vaccination programs in Canada: Are we hitting the mark? Report Card on Cancer in Canada. Available at http://www.canceradvocacy.ca/reportcard/2008/HPV%20Vaccination% 20Programs%20in%20Canada.pdf (2008). Accessed September 2013.
10. Shearer BD: HPV Vaccination: Understanding the Impact on HPV disease. Winnipeg, MB: National Collaborating Centre for Infectious Diseases; 2011:1-18.
11. Medical Officer of Health. Toronto Public Health: Human Papillomavirus Vaccination Program Update (2008). Available at http://www.toronto.ca/legdocs/mmis/2008/hl/decisions/2008-09-18-hl17-dd.pdf (2011). Accessed September 2013.
12. Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JML: Human Papillomavirus Vaccine Introduction - The First Five Years. Vaccine 2012, 30(Suppl 5):F139-F148.
13. Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P: Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007-2012. Vaccine 2014, 32:2150-2159.
14. Kumar S, Quinn SC, Kim SH, Musa D, Hilyard KM, Freimuth VS: The social ecological model as a framework for determinants of 2009 H1N1 influenza vaccine uptake in the United States. Health Educ Behav 2012, 39(2):229-243.
15. Reiter PL, Brewer NT, Gottlieb SL, McRee A-L, Smith JS: Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 2009, 69(3):475-480.
16. Brewer NT, Fazekas KI: Predictors of HPV vaccine acceptability: a theoryinformed, systematic review. Prev Med 2007, 45(2-3):107-114.
17. Ontario Ministry of Health and Long-Term Care: Ontario's HPV Vaccination Program. Available at http://www.health.gov.on.ca/en/ms/hpv/immunize. aspx (2013) Accessed May 2013.
18. Juurlink D, Preyra C, Croxford R, Chong A, Austin P, Tu J, Laupacis A: Canadian Institute for Health Information Discharge Abstract Database: a validation study. Institute for Clinical Evaluative Sciences; 2006.
19. Improving Health Care Data in Ontario. ICES Investigative Report. Toronto: Institute for Clinical Evaluative Sciences; 2005.
20. Institute for Clinical Evaluative Sciences: Data & Programming at ICES. Outside ICES. Available from https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx.
21. Iron K: Moving Toward a Better Health Data System for Ontario. Toronto: Institute for Clinical Evaluative Sciences; 2006.
22. Iron K, Manuel DG: Quality Assessment of Administrative Data: An Opportunity for Enhancing Ontario's Health Data. ICES Investigative Report. Toronto: Institute for Clinical Evaluative Sciences; 2007.
23. Smith LM, Brassard P, Kwong JC, Deeks SL, Ellis AK, Levesque LE: Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of Grade 8 girls. BMC Public Health 2011, 11:645.
24. Lim WT, Sears K, Smith LM, Liu G, Levesque LE: Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV vaccine cohort study. BMC Public Health 2014, In Press.
25. Ontario Ministry of Health and Long-Term Care: Immunization Management Protocol. Available at http://www.health.gov.on.ca/en/pro/programs/publichealth/oph-standards/docs/immunization-management.pdf (2013) Accessed July 2013.
26. Smith LM, Levesque LE, Nasr M, Perry AG: Validity of the Immunization Record Information System (IRIS) database for epidemiologic studies of the human papillomavirus (HPV) vaccine. Can J Clin Pharmacol 2010, 17(1):e90-e127. Abstract.
27. Statistics Canada: Census of Canada. Available at http://www12.statcan.gc. ca/census-recensement/index-eng.cfm (2013) Accessed January 2013.
28. Lévesque LE, Smith LM, Perry AG, Nsar M, Hogan ML, Martin A, Monreal M: The Ontario Grade 8 HPV Vaccine Cohort Study: A Feasibility and Validity Evaluation. Toronto, ON: Ontario Vaccine Sciences Symposium; 2011.
29. Pampalon R, Hamel D, Gamache P, Raymond G: A deprivation index for health planning in Canada. Chronic Dis Can 2009, 29(4):178-191.
30. Hatcher L: Step by Step Approach to Using the SAS System for Factor Analysis and Structural Equation Modelling. Cary, NC: SAS Institute Inc.; 1994.
31. Eheman C, Henley SJ, Ballard-Barbash R, Jacobs EJ, Schymura MJ, Noone AM, Pan L, Anderson RN, Fulton JE, Kohler BA, Jemal A, Ward E, Plescia M, Ries LA, Edwards BK: Annual report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 2012, 18(9):2338-2366.
32. Melyn MA, White DT: Mental and developmental milestones of noninstitutionalized Down's Syndome children. Pediatrics 1973, 52:542-545.
33. Hurlbutt KS: Experiences of parents who homeschool their children with autism spectrum disorders. Focus Autism Other Dev Disabl 2011, 26(4):239-249.
34. Pownall JD, Jahoda A, Hastings RP: Sexuality and sex education of adolescents with intellectual disability: mother's attitudes, experiences, and support needs. J Intellect Dev Disabil 2012, 50(2):140-154.
35. Cuskelly M, Bryde R: Attitudes towards the sexuality of adults with an intellectual disability: parents, support staff, and a community sample. J Intellect Dev Disabil 2004, 29:255-264.
36. Smith N, Harrell S: Sexual abuse of children with disabilities: a national snapshot. Issue Brief, Center on Victimization and Safety, U.S. VERA Institute of Justice. (2013). Available at: http://www.vera.org/sites/default/files/resources/downloads/sexual-abuse-of-children-with-disabilities-nationalsnapshot.pdf Accessed December 2012.
37. Zimet GD: Improving adolescent health: Focus on HPV vaccine acceptance. J Adolesc Health 2005, 37:S17-S23.
38. Gonik B: Strategies for fostering HPV vaccine acceptance. Infect Dis Obstet Gynecol 2006, 36797:1-4.
39. Mackillop WJ, Zhang-Salomons J, Boyd CJ, Groome PA: Associations between community income and cancer incidence in Canada and the United States. Cancer 2000, 89(901):912.
40. Ng E, Wilkins R, Fung MF, Berthelot JM: Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996. CMAJ 2010, 170(10):1545-1549.
41. Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, Patrick DM, Naus M: A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PloS Med 2010, 7(5):e1000270.